Efficaciousness of Blood Transfusion Therapy in Cancer Treatment

Medical doctors who attend to the terminally ill on a daily basis experience many soul searching moments every time they are left with the death of a patient. They also face the sobering reminder of limitations on what therapeutic services they can truly provide to save the lives of their patients.

This is especially apparent in the treatment of terminal stage cancer patients. Doctors who are often without any available precedent for successful treatment have no alternative but to practice safe, “status quo” defensive medicine. They shy away from or simply give up on a “terminal” case without attempting at any form of curative treatment for fear of failure and malpractice law suits.

A striking example of this status quo treatment is blood transfusion therapy. Unknown to most, late stage cancer patients often face dangers of sudden death from loss of blood. Blood loss occurs from failing metabolic functions and compensatory vasoconstriction evoked by hemorrhage. For this condition, blood transfusion is a generally accepted and widely used method of treatment for immediate replacement of lost blood. However, there is abundant evidence of immune and non-immune modulation induced by exposure to blood transfusion. Some studies have demonstrated a detrimental effect of transfusion on the recurrence of malignant diseases. Continued exposure to blood transfusion introduces complication reactions which may severely and permanently interfere with survival and/or complete remission.

If the long term therapeutic goal is for a complete remission or cure from cancer, then, even with risk of death from blood loss, proper aggressive treatment should occur without exposing the patient to blood transfusion. In fact, one of the most important determining factors in prognosis is the absence of any exposure to transfusion. However, in the U.S., the threat of malpractice lawsuits prevents many doctors from incorporating any such “risky” therapies into their methods of treatment.

Late stage cancer patients thus often suffer from circulatory complications such as heart attacks, and, no matter what emergency measures are stylized, the patient ultimately dies in pain.

The objective here is not to dismiss the undeniably productive aspects of traditional Western medicine, but to enlighten readers to “alternative” paths to recovery and health.

Although acupuncture has evolved for thousands of years in the Orient, acupuncture is recognized only as an instrument for pain control in the U.S. With the combined use of Korean acupuncture and herbal medicine, not only terminal stage cancer but other serious, life-threatening diseases and illnesses can and have been completely treated.

Western medicine, where theories or techniques are central to the understanding of, is not emphasized in Oriental medicine. Instead, the educational approach of Oriental medicine is comparable to the inheritance of family heirlooms. Korean (KyungHak) Oriental medicine is taught and trained – through inheritance – to select disciplined individuals with ties or connections. Diagnosis and treatment in Oriental medicine occurs through communication and cooperation between the patient and the doctor.